News
Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to ...
17h
ET Now on MSNGlenmark Pharma shares hit 10% upper circuit after THIS newsIn a regulatory filing made post-market hours on July 10, Glenmark announced that its wholly-owned step-down subsidiary, Ichnos Glenmark Innovation (IGI), has signed an exclusive worldwide licensing ...
Glenmark Pharma's stock surged 10 per cent to Rs 2,094, reaching the upper circuit during the initial trading session on 11 ...
Inch Wafer Foundry Market is Segmented by Type (Cutting-Edge (3/5/7nm), 10/14/16/20/28nm, 40/45/65/90nm), by Application ...
Lupin (Lupin) and Zentiva Group (Zentiva), a pan-European pharmaceutical company, have entered into a license and supply agreement for commercialization of Lupin's biosimilar Certolizumab Pegol, ...
Pharma major Lupin Ltd on Wednesday said it has inked a license and supply pact for commercialisation of its biosimilar 'Certolizumab Pegol' across multiple global markets with the Zentiva Group, ...
Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...
Lupin announced that it has entered into a license and supply agreement with Zentiva, k.s. for the commercialization of its biosimilar Certolizumab Pegol.
WASHINGTON − President-elect Donald Trump threatened the BRIC group of emerging-market nations on Saturday, warning that he would impose 100% tariffs if they make any moves to undermine the U.S ...
AlHuda Centre of Islamic Banking and Economics (CIBE), a global leader in Islamic finance development, proudly highlights the ...
In an exchange filing, the company said that it secured two prestigious export orders from the Commonwealth of Independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results